A plain-language guide

tuberous sclerosis complex

What's known, what's still uncertain, and what's actively debated, written plainly, and built only from published medical research.

Growing map · 26 sourced statements Every statement names its source Updated 2026-08-04
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. tuberous sclerosis complex is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What's tuberous sclerosis complex?

Tuberous sclerosis complex is an autosomal dominant, multisystem neurocutaneous disorder caused by loss-of-function variants in the tumour-suppressor genes TSC1 (hamartin) or TSC2 (tuberin), which leads to dysregulation of the mTOR pathway and benign hamartomas across many organs. Hallmark features include hypomelanotic macules, facial angiofibromas, shagreen patch, cortical tubers with epilepsy (including infantile spasms), subependymal nodules and giant-cell astrocytoma, renal angiomyolipomas, cardiac rhabdomyomas, and TSC-associated neuropsychiatric disorder (TAND). mTOR inhibitors (everolimus, sirolimus) are targeted disease therapies, and vigabatrin is first choice for infantile spasms.

Also indexed asORPHA:805, MONDO:0001734
Features mapped15
Treatments mapped2
Published sources12
Last reviewed2026-08-04

Signs and symptoms

Subependymal giant-cell astrocytoma

A subependymal giant-cell astrocytoma (SEGA) is a slow-growing brain tumor that can develop from a subependymal nodule and block the flow of brain fluid, so it is monitored with brain imaging.

Limited evidenceSource: PMID:39982781
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41984558, ORPHA:805
Notesplain_language confirmed from PMID:41984558 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:39982781 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Subependymal nodules

Subependymal nodules are small benign growths lining the fluid spaces of the brain. They are common and are watched because a few can grow into a SEGA.

Limited evidenceSource: PMID:37946245
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41984558, ORPHA:805
Notesplain_language confirmed from PMID:41984558 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:37946245 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Ungual fibroma

Small fleshy growths around or under the finger- and toenails (ungual or periungual fibromas) are a skin feature of TSC, usually appearing later in childhood or adulthood.

Limited evidenceSource: PMID:34303387
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:15309659, ORPHA:805
Notesplain_language confirmed from PMID:15309659 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary ORPHA:805 -> PMID:34303387 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Cortical tubers

Cortical tubers are areas of abnormally formed brain tissue. They are a hallmark of the condition and are closely linked to epilepsy.

Limited evidenceSource: PMID:37946245
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41984558, ORPHA:805
Notesplain_language confirmed from PMID:41984558 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:37946245 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Angiofibromas

Facial angiofibromas are small reddish bumps that develop across the cheeks and nose, usually appearing in childhood. They are one of the most recognizable skin signs.

Limited evidenceSource: PMID:42265631
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:39727664, ORPHA:805
Notesplain_language confirmed from PMID:39727664 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:42265631 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Renal angiomyolipoma

Renal angiomyolipomas are benign tumors of the kidneys. They are common and matter because larger ones can bleed, which is a major source of illness in the condition.

Limited evidenceSource: PMID:42265631
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41982247, ORPHA:805
Notesplain_language confirmed from PMID:41982247 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:42265631 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Cardiac rhabdomyoma

Cardiac rhabdomyomas are benign heart-muscle tumors, often present before birth. Many shrink on their own over time, but large ones can cause problems early in life.

Limited evidenceSource: PMID:37946245
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42187286, ORPHA:805
Notesplain_language confirmed from PMID:42187286 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:37946245 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Shagreen patch

A shagreen patch is a raised area of thickened, leathery skin, usually on the lower back, and is a characteristic skin feature.

Limited evidenceSource: PMID:42265631
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42252216, ORPHA:805
Notesplain_language confirmed from PMID:42252216 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:42265631 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Seizure

Seizures are common and often begin in infancy. Controlling them is one of the central goals of care because frequent early seizures can affect development.

Limited evidenceSource: PMID:38137462
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:39448920, ORPHA:805
Notesplain_language confirmed from PMID:39448920 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:38137462 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Cortical dysplasia

In the brain, TSC causes areas of abnormal development. Cortical tubers (a kind of focal cortical dysplasia) and subependymal nodules are characteristic and are often what seizures arise from.

Limited evidenceSource: PMID:41908340
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:17314448, ORPHA:805
Notesplain_language confirmed from PMID:17314448 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary ORPHA:805 -> PMID:41908340 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Infantile spasms

Infantile spasms are a particular seizure type that can appear in babies with the condition. They need prompt treatment because they can harm development if untreated.

Limited evidenceSource: PMID:38137462
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42151856, ORPHA:805
Notesplain_language confirmed from PMID:42151856 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:38137462 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Autistic behavior

TSC affects the brain in ways that go beyond seizures. Autism spectrum disorder and other neuropsychiatric features (together called TAND) are common and benefit from screening and support.

Limited evidenceSource: PMID:39891979
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:39727664, ORPHA:805
Notesplain_language confirmed from PMID:39727664 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary ORPHA:805 -> PMID:39891979 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Autism

Neurodevelopmental and behavioral effects, including autism spectrum disorder, are common and are grouped together as TSC-associated neuropsychiatric disorder (TAND).

Limited evidenceSource: PMID:41820375
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:39727664, ORPHA:805
Notesplain_language confirmed from PMID:39727664 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:41820375 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Epileptic spasm

Seizures are common in TSC and often begin in infancy. Early-onset infantile spasms (a distinctive seizure type in babies) are a hallmark and need prompt treatment to protect development.

Limited evidenceCurated reference: ORPHA:805
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:39727664
Notesplain_language confirmed from PMID:39727664 via curation 2026-06-18 [claude (tier3 curation)].
Last reviewed2026-06-18

Hypomelanotic macule

Hypomelanotic macules, often called ash-leaf spots, are pale patches of skin that are usually present from birth or early infancy and are often the earliest visible sign.

Limited evidenceSource: PMID:42265631
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42252216, ORPHA:805
Notesplain_language confirmed from PMID:42252216 via curation 2026-06-14. | regrounded primary ORPHA:805 -> PMID:42265631 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

How it is diagnosed

Tuberous sclerosis complex

Diagnosed using: Brain MRI.

Limited evidenceSource: PMID:17314448
The source text this rests on
“Magnetic resonance imaging of the brain showed cortical tubers and subependymal nodules; which are diagnostic of…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:17314448 via curation 2026-06-18
Last reviewed2026-06-18

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

everolimus

Everolimus is an mTOR-inhibitor medicine that targets the overactive growth pathway underlying the condition. It can shrink SEGAs and kidney angiomyolipomas and reduce seizures, treating several manifestations at once.

Used to help with: Tuberous sclerosis complex.

Limited evidenceSource: PMID:39448920
The source text this rests on
“Everolimus is an inhibitor for mTORC1 and is currently used to treat TSC for its main role in rapidly reducing SEGA volume and seizure burden, although mainly studied in the adult population.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:39448920 via curation 2026-06-14
Last reviewed2026-06-14

vigabatrin

Vigabatrin is the medicine of choice for infantile spasms in this condition and is often started early to control them.

Used to help with: Infantile spasms.

Limited evidenceSource: PMID:42151856
The source text this rests on
“METHODS: The authors report a five-year-old girl with Tuberous Sclerosis Complex who was initiated on vigabatrin at seven weeks old to treat infantile spasms and on everolimus at two months of age to treat a subependymal giant cell astrocytoma.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:42151856 via curation 2026-06-14
Last reviewed2026-06-14

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.

Where this comes from

This guide is built from 12 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

ORPHA:805 · Orphanet/HPO annotations for Tuberous sclerosis complex
PMID:17314448 · Coexistence of two neurocutaneous syndromes: tuberous sclerosis and hypomelanosis of Ito.
PMID:34303387 · Tuberous Sclerosis.
PMID:37946245 · A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex.
PMID:38137462 · The Evolving Landscape of Therapeutics for Epilepsy in Tuberous Sclerosis Complex.
PMID:39448920 · Everolimus on cystic kidney disease burden reduction in pediatric tuberous sclerosis complex patients: a case series.
PMID:39891979 · Intellectual disability and autistic behavior and their modifying factors in children with tuberous sclerosis complex.
PMID:39982781 · Phenotypic clustering in tuberous sclerosis complex reveals four distinct disease trajectories.
PMID:41820375 · Tuberous sclerosis complex.
PMID:41908340 · Comparative Evaluation of CT and MRI in Detecting Intracranial and Extracranial Manifestations of Tuberous Sclerosis Complex.
PMID:42151856 · Early neurodevelopmental outcomes in a child with tuberous sclerosis complex treated with everolimus and vigabatrin.
PMID:42265631 · Genotypic and phenotypic features of 23 Egyptian patients with tuberous sclerosis complex.

Take it further

Printed, source-linked documents built from this condition's graph — ready to bring to an appointment or attach to a coverage request. Every claim carries its published source, the same as this guide.